Page last updated: 2024-09-03

exp7711 and telmisartan

exp7711 has been researched along with telmisartan in 2 studies

Compound Research Comparison

Studies (exp7711)	Trials (exp7711)	Recent Studies (post-2010) (exp7711)	Studies (telmisartan)	Trials (telmisartan)	Recent Studies (post-2010) (telmisartan)
18	0	1	1,930	480	1,038

Protein Interaction Comparison

Protein	Taxonomy	telmisartan (IC50)
Cytochrome P450 2C9	Homo sapiens (human)	0.42
Type-1 angiotensin II receptor	Homo sapiens (human)	0.0179
Type-2 angiotensin II receptor	Homo sapiens (human)	0.0003
Cytochrome P450 2J2	Homo sapiens (human)	0.5
Solute carrier organic anion transporter family member 1B3	Homo sapiens (human)	1.2589
Solute carrier organic anion transporter family member 1B1	Homo sapiens (human)	1.8621

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Entzeroth, M; Hasselbach, KM; Hauel, NH; Mihm, G; Narr, B; Ries, UJ; van Meel, JC; Wienen, W; Wittneben, H	1
Berellini, G; Cruciani, G; Mannhold, R	1

Other Studies

2 other study(ies) available for exp7711 and telmisartan

Article	Year
6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships. Journal of medicinal chemistry, 1993, Dec-10, Volume: 36, Issue:25 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Binding Sites; Blood Pressure; Male; Models, Molecular; Rats; Rats, Wistar; Receptors, Angiotensin; Structure-Activity Relationship; Telmisartan	1993
Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists. Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Binding Sites; Biphenyl Compounds; Kinetics; Losartan; Models, Molecular; Molecular Conformation; Oxidation-Reduction; Pharmaceutical Preparations; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Tetrazoles	2005

Article

Year

6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.

Journal of medicinal chemistry, 1993, Dec-10, Volume: 36, Issue:25

Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Binding Sites; Blood Pressure; Male; Models, Molecular; Rats; Rats, Wistar; Receptors, Angiotensin; Structure-Activity Relationship; Telmisartan

1993

Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.

Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Binding Sites; Biphenyl Compounds; Kinetics; Losartan; Models, Molecular; Molecular Conformation; Oxidation-Reduction; Pharmaceutical Preparations; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Tetrazoles

2005